Page last updated: 2024-08-24

ranolazine and Anasarca

ranolazine has been researched along with Anasarca in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Arndt, TL; Bennett, NM; Garberich, RF; Henry, TD; Schmidt, CW; Storey, KM; Traverse, JH; Wang, J1
Davangeri, R; Hashilkar, NK; Majagi, SI; Naveena, R1
Chatterjee, S; Ilayaraja, M; Majumder, S; Seerapu, HR; Siamwala, JH; Sinha, S1

Other Studies

3 other study(ies) available for ranolazine and Anasarca

ArticleYear
Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
    The American journal of cardiology, 2020, 08-15, Volume: 129

    Topics: Aged; Angina Pectoris; Cardiovascular Agents; Constipation; Deprescriptions; Diabetes Mellitus; Disease Progression; Dizziness; Drug Costs; Dyslipidemias; Edema; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Nausea; Ranolazine; Registries; Smoking; Treatment Failure; Treatment Outcome

2020
Effect of anti-inflammatory activity of ranolazine in rat model of inflammation.
    The Indian journal of medical research, 2018, Volume: 148, Issue:6

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carrageenan; Edema; Granuloma, Foreign-Body; Gum Arabic; Inflammation; Male; Random Allocation; Ranolazine; Rats, Wistar

2018
Chick embryo partial ischemia model: a new approach to study ischemia ex vivo.
    PloS one, 2010, May-07, Volume: 5, Issue:5

    Topics: Acetanilides; Animals; Apoptosis; Blood Vessels; Cell Proliferation; Cell Survival; Chick Embryo; Creatine Kinase, MB Form; Disease Models, Animal; Edema; Endothelial Cells; Glutathione; Goats; Health; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Myocardium; Neovascularization, Pathologic; Organ Specificity; Piperazines; Ranolazine; Reactive Oxygen Species; Time Factors; Vascular Surgical Procedures

2010